Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free Strategy

Patients with uHCC who achieve pCR after systemic therapy and curative resection exhibit favorable long-term outcomes. Active surveillance yields comparable survival to adjuvant therapy with reduced toxicity. A "Tumor-Free with Drug-Free" strategy may be feasible in patients with normalized postoperative AFP levels, while those with persistent AFP positivity may represent a high-risk subgroup requiring individualized postoperative management.

Authors

Institutions

Publication Details

Journal
Liver Cancer
Published
2025-11-28
DOI
https://doi.org/10.1159/000549793
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free Strategy

Dandan Hu, Yizhen Fu, Xiaohui Wang, Zhenyun Yang et al.
Liver Cancer
Hepatocellular Carcinoma Treatment and Prognosis
article

Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free Strategy

Dandan Hu, Yizhen Fu, Xiaohui Wang, Zhenyun Yang, Wei Peng, Zili Hu, X. Yu, Jinbin Chen, Keli Yang, Shunli Shen, Jun-Cheng Wang, Zihan Song, Ma Luo, Qiongyan Lin, Minshan Chen, Yao‐Jun Zhang, Zhong-Guo Zhou, Fan Xie
article en

Abstract

Patients with uHCC who achieve pCR after systemic therapy and curative resection exhibit favorable long-term outcomes. Active surveillance yields comparable survival to adjuvant therapy with reduced toxicity. A "Tumor-Free with Drug-Free" strategy may be feasible in patients with normalized postoperative AFP levels, while those with persistent AFP positivity may represent a high-risk subgroup requiring individualized postoperative management.

Liver Cancer
Sun Yat-sen University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Sun Yat-sen University Cancer Center (CN), Hunan Provincial People's Hospital (CN), Guangzhou Eighth People's Hospital (CN), Guangzhou Medical University (CN)
National Natural Science Foundation of China, Sun Yat-sen University, Guangzhou Municipal Science and Technology Bureau, Fundamental Research Funds for the Central Universities, Basic and Applied Basic Research Foundation of Guangdong Province
Openalex Percentile: Top 51%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.